The Therapeutic Potential of Pristimerin in Osteoarthritis: Mechanistic Insights from in vitro and in vivo Studies

被引:0
作者
Yin, Li [1 ,2 ,3 ,4 ]
Fan, Yong [1 ,2 ,3 ,4 ]
Zhong, Xugang [1 ,3 ,4 ]
Meng, Xiang [1 ,3 ,4 ]
He, Zeju [1 ,3 ,4 ]
Hong, Zheping [1 ,3 ,4 ]
Chen, Jihang [1 ,3 ,4 ]
Zhang, Qiong [5 ]
Kong, Mingxiang [1 ,3 ,4 ]
Wang, Jiao [1 ,3 ,4 ]
Tong, Yu [1 ,3 ,4 ]
Bi, Qing [1 ,2 ,3 ,4 ]
机构
[1] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Dept Sports Med, Hangzhou 310000, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Postgrad Training Base Alliance, Wenzhou 325000, Zhejiang, Peoples R China
[3] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Ctr Rehabil Med,Dept Orthoped, Hangzhou 310000, Zhejiang, Peoples R China
[4] Hangzhou Med Coll, Inst Sports Med & Osteoarthropathy, Hangzhou 310000, Zhejiang, Peoples R China
[5] Hangzhou Med Coll, Zhejiang Prov Peoples Hosp, Affiliated Peoples Hosp, Dept Nursing, Hangzhou 310000, Zhejiang, Peoples R China
来源
DRUG DESIGN DEVELOPMENT AND THERAPY | 2024年 / 18卷
关键词
pristimerin; MAPK/NF-kappa B; chondrocyte inflammation; cartilage protection; osteoarthritis; RNA transcriptome sequencing; HAND OSTEOARTHRITIS; KNEE; HIP; EPIDEMIOLOGY; INDUCTION; COX-2; RISK;
D O I
10.2147/DDDT.S490388
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Objective: Osteoarthritis (OA), a degenerative disease marked by cartilage erosion and synovial proliferation, has led to an increased interest in natural plant-based compounds to slow its progression. Pristimerin(Pri), a triterpenoid compound derived from Tripterygium wilfordii, has demonstrated anti-inflammatory and antioxidant characteristics. This study explores the protective effects of Pri on OA and its potential mechanisms. Methods: In this study, we examined the impact of Pri on the expression of inflammatory factors and extracellular matrix(ECM) degradation induced by IL-1(3 in chondrocyte experiments. Bioinformatics analysis was then performed to investigate the potential signaling pathways involved in Pri's protective effects. Finally, the efficacy of Pri in reducing cartilage degradation was further evaluated in a destabilization of the medial meniscus (DMM) mouse model. Results: Utilizing bioinformatics analysis and in vitro studies, it was revealed that Pri inhibits the activation of NF-kappa B and MAPK signaling pathways, leading to the reversal of upregulated MMP-13 (matrix metalloproteinases-13), iNOS (inducible nitric oxide synthase), and COX-2(cyclooxygenase-2) elicited by IL-1(3 stimulation, as well as the partial restoration of Collagen-II levels. Furthermore, in a DMM mouse model, the group treated with Pri exhibited reduced cartilage degradation and slowed OA progression compared to the modeling group. Conclusion: This research highlights Pri as a potential therapeutic agent for delaying OA progression.
引用
收藏
页码:5445 / 5459
页数:15
相关论文
共 50 条
  • [21] A low dose cell therapy system for treating osteoarthritis: In vivo study and in vitro mechanistic investigations
    Wang, Bin
    Liu, Wei
    Li, Jiao Jiao
    Chai, Senlin
    Xing, Dan
    Yu, Hongsheng
    Zhang, Yuanyuan
    Yan, Wenjin
    Xu, Zhihong
    Zhao, Bin
    Du, Yanan
    Jiang, Qing
    BIOACTIVE MATERIALS, 2022, 7 : 478 - 490
  • [22] Is Cartilage Matrix Breakdown an Appropriate Therapeutic Target in Osteoarthritis - Insights from Studies of Aggrecan and Collagen Proteolysis?
    Little, Christopher B.
    Fosang, Amanda J.
    CURRENT DRUG TARGETS, 2010, 11 (05) : 561 - 575
  • [23] Obesity and cancer: mechanistic insights from transdisciplinary studies
    Allott, Emma H.
    Hursting, Stephen D.
    ENDOCRINE-RELATED CANCER, 2015, 22 (06) : R365 - R386
  • [24] Therapeutic effect of induced pluripotent stem cell-derived extracellular vesicles in an in vitro and in vivo osteoarthritis model
    Hsueh, Yu-Huan
    Buddhakosai, Waradee
    Le, Phung Ngan
    Tu, Yung-Yi
    Huang, Hsien-Chang
    Lu, Huai-En
    Chen, Wen-Liang
    Tu, Yuan-Kun
    JOURNAL OF ORTHOPAEDIC TRANSLATION, 2023, 38 : 141 - 155
  • [25] Anterior knee pain as a potential risk factor for falls in older adults: insights from the osteoarthritis initiative data
    Xiong, Ting
    Ou, Yanghuan
    Chen, Shenliang
    Liu, Shuaigang
    Yi, Xuan
    Deng, Xueqiang
    Cheng, Tao
    Hao, Liang
    BMC PUBLIC HEALTH, 2023, 23 (01)
  • [26] Disease-Associated Particulates and Joint inflammation; Mechanistic insights and Potential Therapeutic Targets
    Mahon, Olwyn R.
    Dunne, Aisling
    FRONTIERS IN IMMUNOLOGY, 2018, 9
  • [27] Mitochondrial quality control in cartilage damage and osteoarthritis: new insights and potential therapeutic targets
    Liu, D.
    Cai, Z-J
    Yang, Y-T
    Lu, W-H
    Pan, L-Y
    Xiao, W-F
    Li, Y-S
    OSTEOARTHRITIS AND CARTILAGE, 2022, 30 (03) : 395 - 405
  • [28] Artemisinin emulgel ameliorates cartilage degradation in knee osteoarthritis: in vitro and in vivo studies
    Thote, Samiksha
    Mourya, Atul
    Arya, Shristi
    Singh, Hoshiyar
    Kumar, Prashanth
    Guru, Santosh Kumar
    Madan, Jitender
    THERAPEUTIC DELIVERY, 2024, : 939 - 955
  • [29] Crosstalk between ferroptosis and chondrocytes in osteoarthritis: a systematic review of in vivo and in vitro studies
    Cao, Siyang
    Wei, Yihao
    Xu, Huihui
    Weng, Jian
    Qi, Tiantian
    Yu, Fei
    Liu, Su
    Xiong, Ao
    Liu, Peng
    Zeng, Hui
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [30] Effects of oral hyaluronic acid on monosodium iodoacetate-induced osteoarthritis in rats: mechanistic insights and therapeutic implications
    Shin, Mi-Rae
    Kim, Minju
    An, Hui Yeon
    Choi, Hwang-Yong
    Ham, Youngseok
    Choi, Hakjoo
    Roh, Seong-Soo
    APPLIED BIOLOGICAL CHEMISTRY, 2024, 67 (01)